Group 1 - The core point of the article is that Fuxin Digital Technology (Hangzhou) Co., Ltd. has completed a Pre-A round financing of 50 million RMB, with participation from Yuan Yi Capital and Changling Capital [1][2]. - Fuxin Digital Technology focuses on the research and application of medical artificial intelligence technology, aiming to drive the transformation of hospitals from informatization to intelligence [2]. - The company was established on April 8, 2015, and is headquartered in Gongshu District, Hangzhou, Zhejiang Province [2]. Group 2 - The financing details include a previous investment of 50 million RMB from Changling Capital during the angel round on March 13, 2023 [2]. - The company's core products are under the "FusionAi" series, which are designed for medical artificial intelligence [2]. - The information is sourced from Tianyancha APP, indicating a reliance on public data for the financing announcement [3].

福鑫数科（杭州）人工智能有限公司（原湖北福鑫科创信息技术有限公司，以下简称"福鑫数科"）近日正式宣布完成5000万元人民币Pre-A轮融资。本轮融 资由远毅资本领投、老股东长岭资本超额追投，光源资本担任独家财务顾问。融资资金将主要用于FusionAi系列医疗人工智能产品的技术迭代、全国规模化 落地和渠道建设以及人才团队的进一步扩充，持续巩固公司在医疗人工智能领域的领先地位。 当前，随着政策推动、技术革新与老龄化加剧等因素的叠加，中国医疗行业信息化（HIT）市场已迈入千亿规模阶段。生成式人工智能的兴起，为医疗信息 化行业革新带来前所未有的发展机遇。相较于传统医疗信息技术，生成式人工智能凭借其对自然语言理解、生成与智能推理能力，为破解医生工作负荷高、 医院运营和收入压力大、系统定制成本高等系统性难题提供了全新路径。基于对此趋势的深刻洞察，福鑫数科率先提出"AI驱动医院全流程"理念，推动生成 式人工智能从辅助工具走向医院临床和运营系统体系的系统性重塑。 福鑫数科将这一战略具象化为医院的"FSD时刻"（Full Self Driving，全自动驾驶）——用人工智能能力重新定义医院运营中的数据治理、患者管理、患者服 务 ...

Core Viewpoint - Fuxin Digital Technology (Hangzhou) Co., Ltd. has completed a Pre-A round financing of 50 million RMB, which will be used to enhance its FusionAi series of medical AI products and solidify its leading position in the medical AI field [1] Company Overview - Founded in 2017, Fuxin Digital Technology focuses on medical informationization and AI applications, with headquarters in Hangzhou and service centers in Wuhan and Beijing [2] - The company aims to drive hospitals towards "intelligent decision-making" by deeply integrating generative AI into core business systems and service frameworks [2] Product and Technology - The FusionAi medical AI system serves as the core engine for hospital intelligence, covering pre-diagnosis, in-diagnosis, post-diagnosis, and data governance [5][7] - FusionAi integrates heterogeneous data within hospitals, enabling structured reconstruction and cleaning, and helps in identifying potential risk patients and optimizing resource allocation [7] - The system supports personalized health management and enhances patient service efficiency through AI-driven digital assistants [7][8] - FusionAi's capabilities extend to generating electronic medical records, improving documentation efficiency, and seamlessly integrating with existing hospital systems [8] Financing Significance and Market Layout - The recent financing will accelerate the nationwide rollout of the FusionAi platform, focusing on benchmark hospital projects in key cities [10] - The investment reflects confidence in the trend of integrating AI with medical informationization, as demand for AI-driven solutions is expected to grow rapidly [10]

Core Insights - Fuxin Digital Technology (Hangzhou) Co., Ltd. has completed a Pre-A round financing of 50 million RMB [1] - The financing was led by Yuan Yi Capital, with existing shareholder Changling Capital participating significantly [1] - The funds will be primarily used for the technological iteration of FusionAi series medical AI products, nationwide scaling, channel development, and team expansion [1] Company Summary - Fuxin Digital Technology has rebranded from Hubei Fuxin Kechuang Information Technology Co., Ltd. [1] - The company focuses on developing medical artificial intelligence products [1] Investment Details - The total amount raised in this financing round is 50 million RMB, equivalent to approximately 7.1 million USD [1] - Yuan Yi Capital is the lead investor in this round [1] - Changling Capital, an existing investor, has increased its investment in this round [1]